# The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia

> **NCT06904859** · EARLY_PHASE1 · COMPLETED · sponsor: **Shenzhen University General Hospital** · enrollment: 50 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)

## Interventions

- **BIOLOGICAL:** TCR-T Cells Injection

## Key facts

- **NCT ID:** NCT06904859
- **Lead sponsor:** Shenzhen University General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-12-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06904859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06904859, "The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06904859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*